✦ LIBER ✦

Role of nuclear medicine in the treatment of malignant gliomas: the locoregional radioimmunotherapy approach

✍ Scribed by P. Riva; G. Franceschi; N. Riva; M. Casi; M. Santimaria; M. Adamo

Book ID: 105965102
Publisher: Springer
Year: 2000
Tongue: English
Weight: 133 KB
Volume: 27
Category: Article
ISSN: 0340-6997
DOI: 10.1007/s002590050549

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Optimal role of temozolomide in the trea

Optimal role of temozolomide in the treatment of malignant gliomas

✍ Roger Stupp; Martin J. van den Bent; Monika E. Hegi 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 400 KB

Advances in the Treatment of Malignant G

Advances in the Treatment of Malignant Gliomas

✍ Mustafa Khasraw; Andrew B. Lassman 📂 Article 📅 2010 🏛 Current Science Inc. 🌐 English ⚖ 209 KB

The potential role of lonidamine (LND) i

The potential role of lonidamine (LND) in the treatment of malignant glioma

✍ Carmine M. Carapella; Marco G. Paggi; Fabio Cattani; Giovanni B. Ciottoli; Arist 📂 Article 📅 1989 🏛 Springer US 🌐 English ⚖ 397 KB

Up-to-date unsatisfactory results obtained in multimodality treatments of malignant glioma have prompted the research of new therapeutic modalities with 'unconventional' modes of action. Lonidamine (LND) is a drug which reduces aerobic glycolytic activity in both human and experimental tumors. This

Misonidazole parameters in the treatment

Misonidazole parameters in the treatment of malignant gliomas

✍ D.A. Pistenma; T.A. Strike 📂 Article 📅 1981 🏛 Elsevier Science 🌐 English ⚖ 97 KB

Temozolomide in the treatment of recurre

Temozolomide in the treatment of recurrent malignant glioma

✍ Susan M. Chang; Philip Theodosopoulos; Kathleen Lamborn; Mary Malec; Jane Rabbit 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB 👁 1 views

## Abstract ## BACKGROUND Options for chemotherapy at the time of recurrence in patients with malignant glioma are limited. The authors describe the efficacy and safety results of their institution's open‐label, compassionate‐use protocol of temozolomide for patients with recurrent malignant gliom

Status spongiosus in the course of treat

Status spongiosus in the course of treatment of malignant gliomas

✍ Michel Poisson; Jean-Jacques Hauw; Ragay Mashaly; Charles Duyckaerts; Raymond Es 📂 Article 📅 1983 🏛 Springer US 🌐 English ⚖ 867 KB

Two cases of fatal encephalopathy which appeared in the course of treatment of malignant gliomas are described. CT scan showed diffuse, low density, non-enhanced lesions of the white matter. Pathological findings showed that the CT scan aspects corresponded to status spongiosus without demyelination